Published in Health Business Week, May 25th, 2007
For the quarter ended March 31, 2007, revenues were $76.9 million compared to $79.0 million for the first quarter of 2006, representing a decrease of $2.1 million, or 2.7%. A significant portion of this revenue decrease is due to a decrease in revenues associated with non-focus product lines, such as durable medical equipment and infusion therapy. Also contributing to the decrease in revenues was the effect of Company initiatives implemented in late 2006 to improve patient co-pay collections and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week